FLETCHER R JOHN

Average Profitability
<0.0001%
Insider Buys Quantity
11
Insider Buys Sum
$547,190.31
Insider Sells Quantity
5
Insider Sells Sum
$3.06M

Insider Activity of FLETCHER R JOHN

The largest purchase of all time was on 2021-05-17 and amounted to 25000 shares of KORU Medical Systems, Inc. for $107,500.

The largest sale of all time was on 2020-05-28 and amounted to 50750 shares of Axcelis Technologies, Inc. for $1.35M.

Biography of FLETCHER R JOHN

No biography is available at this moment.

2021-05-17PurchaseKORU Medical Systems, Inc.
KRMD
director
25,000
0.0563%
$4.30$107,500-28.44%
2021-02-17SaleAxcelis Technologies, Inc.
ACLS
director
6,881
0.0201%
$39.00$268,359+15.41%
2020-12-01PurchaseKORU Medical Systems, Inc.
KRMD
director
1,275
0.0028%
$4.53$5,776-26.63%
2020-11-30PurchaseKORU Medical Systems, Inc.
KRMD
director
21,052
0.05%
$4.48$94,313-20%
2020-05-28SaleAxcelis Technologies, Inc.
ACLS
director
50,750
0.1588%
$26.52$1.35M+10.94%
2019-12-12SaleAxcelis Technologies, Inc.
ACLS
director
20,000
0.0613%
$23.52$470,400+4.08%
2019-12-11SaleAxcelis Technologies, Inc.
ACLS
director
22,500
0.0686%
$22.96$516,600+6.04%
2019-03-13SaleAxcelis Technologies, Inc.
ACLS
director
22,500
0.0691%
$20.26$455,950-1.09%
2014-05-22PurchaseAxcelis Technologies, Inc.
ACLS
director
10,000
0.0089%
$1.73$17,300+24.71%
2013-08-08PurchaseAxcelis Technologies, Inc.
ACLS
director
20,000
0.0179%
$1.84$36,800+15.08%
2012-05-25PurchaseAxcelis Technologies, Inc.
ACLS
director
10,000
0.0086%
$1.04$10,400+2.68%
2011-02-17PurchaseAxcelis Technologies, Inc.
ACLS
director
20,000
0.0189%
$2.85$56,980-42.25%
2007-08-24PurchaseAxcelis Technologies, Inc.
ACLS
director
20,000
0.0196%
$4.88$97,600+3.08%
2004-12-17PurchaseAxcelis Technologies, Inc.
ACLS
director
4,000
0.0039%
$8.01$32,040-16.67%
2004-09-15PurchaseAxcelis Technologies, Inc.
ACLS
director
4,000
0.004%
$8.06$32,240-10.15%
2003-12-17PurchaseAxcelis Technologies, Inc.
ACLS
director
6,000
0.006%
$9.37$56,242+5.81%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.